Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 4 25 10 SULFITE FREE IN DEXTROSE 10 IN PLASTIC CONTAINER versus KABIVEN IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 4 25 10 SULFITE FREE IN DEXTROSE 10 IN PLASTIC CONTAINER versus KABIVEN IN PLASTIC CONTAINER.
CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER vs KABIVEN IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
CLINIMIX 4.25/10 is a parenteral nutrition solution providing amino acids (4.25%) for protein synthesis and dextrose (10%) as a carbohydrate calorie source. The amino acids are used for tissue repair and growth, while dextrose provides energy via glycolysis and oxidative phosphorylation.
Kabiven is a parenteral nutrition formulation that provides a balanced mixture of amino acids, dextrose, and lipids to meet nutritional requirements. The amino acids serve as building blocks for protein synthesis, dextrose provides a carbohydrate source for energy, and lipids supply essential fatty acids and additional energy. Electrolytes are included to maintain fluid and electrolyte balance.
Intravenous infusion; typical adult dose is 500-2000 mL per day, providing 4.25 g/100 mL amino acids and 10 g/100 mL dextrose, infused at a rate not exceeding 100 mL/hour initially, adjusted based on metabolic and clinical response.
Intravenous infusion. Adult dose based on nutritional needs: typically 0.8-1.5 g amino acids/kg/day, 0.8-1.5 g lipids/kg/day, and 2-4 g dextrose/kg/day. Maximum infusion rate: 1.7 mL/kg/hour (Kabiven Peripher) or 2.6 mL/kg/hour (Kabiven Central).
None Documented
None Documented
Amino acids: 0.5-2 hours (individual amino acids vary); dextrose: 1-2 hours (insulin-dependent); terminal half-life not defined due to continuous infusion.
Variable; amino acids: 0.5–1 h; lipids: 0.5–1 h (intralipid clearance); glucose: rapid. No true terminal half-life as a mixture.
Renal: 95-100% (as amino acids, glucose, and metabolites); minimal biliary/fecal elimination.
Renal: <3% unchanged; primarily metabolized via protein catabolism; nitrogen excretion is renal (urea, ammonia); fat emulsion components are cleared by the reticuloendothelial system and metabolized. Biliary/fecal: negligible.
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition